Tygacil Drug Use Investigation
This trial is active, not recruiting.
|Conditions||intra-abdominal infections, skin disease, infectious|
|Start date||April 2013|
|End date||June 2017|
|Trial size||100 participants|
|Trial identifier||NCT01789905, B1811187|
To collect retrospectively the effectiveness and safety information of tigecycline related to their appropriate use in daily practice.
Number of Participants with Clinical Response of Cure at the Test-of-Cure (TOC) Visit
time frame: 14 days
Male or female participants of any age.
Inclusion Criteria: - All patients who are prescribed tigecycline (Tygacil). Exclusion Criteria: - Subject who have been prescribed tigecycline (Tygacil).
|Official title||Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-drug Resistance.)|
Call for more information